Anti-inflammatories
-
CRISPR screen identifies new anti-inflammatory drug target
A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics. Read MoreNov 11, 2021
-
A spicy finding
Vanderbilt researchers have discovered that curcumin — the active ingredient in the spice turmeric — needs to be metabolically activated to exert anti-inflammatory effects. Read MoreJan 16, 2018
-
VU, Celgene announce research partnership
Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market. Read MoreJul 10, 2014
-
Inflammation relief: what’s the delay?
New research offers hope for patients needing the anti-inflammatory benefits of glucocorticoids without the adverse side effects associated with them. Read MoreJun 28, 2011